Summary
- The article discusses the increased scrutiny of Chinese pharmaceutical companies like Wuxi by the US Congress.
- Wuxi has become a major player in the drug industry, raising concerns due to its ties to the Chinese government.
- Lawmakers are worried about the potential impact of foreign influence on the US drug supply chain.
- The scrutiny comes amid broader bipartisan concern over US reliance on foreign drug manufacturing.
- The situation highlights the need for transparency and oversight in the pharmaceutical industry.